The Top-50 biopharmaceutical investors in the world (31.01.2019)
The European Commission (@EU_Commission) Industrial R&D Investment Scoreboard 2017/18 comprises of the 2,500 private-sector companies investing the largest sums in research and development in the world . These companies, based in 46 countries, invested a total of €736.4 Bn which is approximately 90% of the world’s business-funded R&D.
The Scoreboard included 154 biopharmaceuticals manufacturers, contributing a total of €138.9 Bn in research and development – approximately 19% of the global estimate. The sector is the one of the most research-intensive in the world. Sixteen of the Top-50 innovative companies in the world are drugmakers.
Here is the list of the Top-fifty biopharmaceutical investors in the world | @heatinformatics
The Scoreboard included 154 biopharmaceuticals manufacturers, contributing a total of €138.9 Bn in research and development – approximately 19% of the global estimate. The sector is the one of the most research-intensive in the world. Sixteen of the Top-50 innovative companies in the world are drugmakers.
Here is the list of the Top-fifty biopharmaceutical investors in the world | @heatinformatics
Artificial Intelligence in Drug Discovery: 2018 Year in Review (26.12.2018)
Martin Vögele on Twitter: https://lnkd.in/etsT4bp “‘We have now reached a stage where the full complexity of real cell membranes is being captured.’ Marrink et al. look back on three decades of membrane simulations and ask ‘what stage comes next?'” https://lnkd.in/eTu7NHB
